Europe’s medical devices scandal

Europe’s medical devices scandal
Medical devices amount to a $400 billion global sector, but don’t face much scrutiny

A major investigation has revealed that many medical devices, including pacemakers, replacement joints and breast implants, have either been tested inadequately or not at all

The inadequate regulation of the pharmaceutical industry has received considerable coverage in media outlets across the world.

In the main, criticism related to the fact that pharmaceutical manufacturers did not have to publish drug trials that had been carried out. In the past, many drug trials went unreported. Inconvenient trial results were regularly buried.

Campaigners have forced the pharmaceutical industry to clean up its act, and trials must now be published on the register of...

Subscribe from just 1€

Exclusive offers

Choose the subscription that is right for you

Monthly Subscription


For the first month

€19.99 Monthly Thereafter

Subscribe today

Cancel anytime

Annual Subscription


For the first year

€199.99 annually thereafter

Subscribe today

Cancel anytime

Quarterly Subscription


For the first 90 days

€55.00 quarterly Thereafter

Subscribe today

Cancel anytime

These offers are not available for current subscribers. Offers and pricing are subject to change without notice.

Terms & Conditions Apply

Please Subscribe or Log in to continue

Subscribe Login

Related Articles

More from The Business Post